
eBreathie is a digital health startup focused on asthma management through a smart inhaler system that monitors inhaler use and inhalation efficacy. Their product integrates a medical device smart inhaler with a mobile app for patients and a management platform for doctors, providing real-time feedback, medication reminders, and personalized reports. The system uses algorithms to identify potential asthma triggers from symptoms, medication, allergens, and air quality data. eBreathie has received awards and recognition, including participation in major health and tech events, and aims to improve respiratory health by reducing asthma attacks and hospitalizations through innovative technology and data-driven insights.

eBreathie is a digital health startup focused on asthma management through a smart inhaler system that monitors inhaler use and inhalation efficacy. Their product integrates a medical device smart inhaler with a mobile app for patients and a management platform for doctors, providing real-time feedback, medication reminders, and personalized reports. The system uses algorithms to identify potential asthma triggers from symptoms, medication, allergens, and air quality data. eBreathie has received awards and recognition, including participation in major health and tech events, and aims to improve respiratory health by reducing asthma attacks and hospitalizations through innovative technology and data-driven insights.
Headquarters: Caparica / Lisbon area, Portugal
Founded: 2021
Product: Smart inhaler device + patient mobile app + clinician management platform
Team size (reported): 4
Funding (reported): Grant funding (records include 2021 and 2023); total reported $50,000 USD
Asthma and respiratory disease management; medication adherence and inhalation technique monitoring.
2021
Digital health / Medical devices
Recorded as a grant-style funding event
$50,000.00
Recorded as a grant-style funding event
“EIT Health and EIT Digital named as supporters/lead supporters in publicly available profiles”